Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

NCT02148185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: MT-1303

Sponsor

Tanabe Pharma Corporation